(0.10%) 5 251.75 points
(0.01%) 39 644 points
(0.22%) 18 294 points
(-0.10%) $78.18
(0.00%) $2.25
(-0.75%) $2 357.10
(-0.71%) $28.31
(-0.03%) $1 006.90
(-0.02%) $0.928
(0.17%) $10.85
(-0.07%) $0.798
(-0.51%) $92.19
@ $0.976
Issued: 7 Feb 2024 @ 15:19
Return: 31.17%
Previous signal: Feb 7 - 13:02
Previous signal:
Return: -0.80 %
Live Chart Being Loaded With Signals
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally...
Stats | |
---|---|
Today's Volume | 2.10M |
Average Volume | 8.35M |
Market Cap | 892.15M |
EPS | $-0.0900 ( 2024-05-07 ) |
Next earnings date | ( $-0.0900 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.66 |
ATR14 | $0.00500 (0.39%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Yu Alice Lin-tsing | Buy | 0 | |
2024-03-28 | Paganelli John A | Buy | 0 | |
2024-03-28 | Lachman Prem A | Buy | 0 | |
2024-03-28 | Pfenniger Richard C Jr | Buy | 0 | |
2024-03-28 | Krasno Richard M | Buy | 0 |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 12 318 025 | Sell: 0 |
Volume Correlation
OPKO Health Inc Correlation
10 Most Negative Correlations | |
---|---|
OMEX | -0.879 |
IMTX | -0.83 |
CFBK | -0.826 |
ANAB | -0.818 |
MGYR | -0.816 |
BKCC | -0.815 |
LNSR | -0.813 |
XOMAP | -0.808 |
CYTK | -0.806 |
INBX | -0.804 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OPKO Health Inc Correlation - Currency/Commodity
OPKO Health Inc Financials
Annual | 2023 |
Revenue: | $863.50M |
Gross Profit: | $232.10M (26.88 %) |
EPS: | $-0.250 |
FY | 2023 |
Revenue: | $863.50M |
Gross Profit: | $232.10M (26.88 %) |
EPS: | $-0.250 |
FY | 2022 |
Revenue: | $1.00B |
Gross Profit: | $288.20M (28.70 %) |
EPS: | $-0.460 |
FY | 2021 |
Revenue: | $1.77B |
Gross Profit: | $581.52M (32.77 %) |
EPS: | $-0.0500 |
Financial Reports:
No articles found.
OPKO Health Inc
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators